Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

作者：Ian Robert Judson, Jaap Verweij, Hans A. J. Gelderblom, Jörg T. Hartmann, Patrick Schöffski, Jean‐Yves Blay, Jan Martijn Kerst, Josef Sufliarsky, Jeremy Whelan, Peter Hohenberger, Anders Krarup‐Hansen, Thierry Alcindor, Sandrine I. Marreaud, Saskia Litière, C. Hermans, Cyril Fisher, Pancras C.W. Hogendoorn, Angelo Paolo Dei Tos, Winette T.A. van der Graaf · 发表于：The Lancet Oncology · 年份：2014 · DOI：10.1016/s1470-2045(14)70063-4 · 被引用次数：1193 · 研究领域：Sarcoma Diagnosis and Treatment、Vascular Tumors and Angiosarcomas、Cardiac tumors and thrombi